Role of α6 nicotinic receptors in CNS dopaminergic function: relevance to addiction and neurological disorders.

No abstract is available for this paper.

• Publication year

  2011

• Venue

  Biochemical Pharmacology

• Publication date

  2011-10-15

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1016/j.bcp.2011.06.001PMID 21684266PMCID PMC3264546
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Brain nicotinic receptors as emerging targets for drug addiction: neurobiology to translational research.

  2011cited by this paper
• Nicotinic receptor agonists decrease L-dopa-induced dyskinesias most effectively in partially lesioned parkinsonian rats.

  2011cited by this paper
• Increased Nicotinic Acetylcholine Receptor Protein Underlies Chronic Nicotine-Induced Up-Regulation of Nicotinic Agonist Binding Sites in Mouse Brain

  2011cited by this paper
• Expression of Functional Human α6β2β3* Acetylcholine Receptors in Xenopus laevis Oocytes Achieved through Subunit Chimeras and Concatamers

  2011cited by this paper
• Nicotinic acetylcholine receptors containing the α4 subunit are critical for the nicotine-induced reduction of acute voluntary ethanol consumption

  2011cited by this paper
• Treatment of nicotine addiction: present therapeutic options and pipeline developments.

  2011cited by this paper
• Partial Agonists of the α3β4* Neuronal Nicotinic Acetylcholine Receptor Reduce Ethanol Consumption and Seeking in Rats

  2011cited by this paper
• Nicotine-Mediated Activation of Dopaminergic Neurons in Distinct Regions of the Ventral Tegmental Area

  2011cited by this paper
• Activation of α4* nAChRs is Necessary and Sufficient for Varenicline-Induced Reduction of Alcohol Consumption

  2010cited by this paper
• α6β2* and α4β2* Nicotinic Receptors Both Regulate Dopamine Signaling with Increased Nigrostriatal Damage: Relevance to Parkinson's Disease

  2010cited by this paper
• Levodopa in Parkinson's disease: from the past to the future

  2010cited by this paper
• Nicotine addiction and nicotinic receptors: lessons from genetically modified mice

  2010cited by this paper
• Striatal Muscarinic Receptors Promote Activity Dependence of Dopamine Transmission via Distinct Receptor Subtypes on Cholinergic Interneurons in Ventral versus Dorsal Striatum

  2010cited by this paper
• Cholinergic Modulation of Locomotion and Striatal Dopamine Release Is Mediated by α6α4* Nicotinic Acetylcholine Receptors

  2010cited by this paper
• Nicotine addiction.

  2010cited by this paper
• Nicotinic Receptor-Mediated Reduction in l-DOPA-Induced Dyskinesias May Occur via Desensitization

  2010cited by this paper
• Maladaptive striatal plasticity in L-DOPA-induced dyskinesia.

  2010cited by this paper
• α-Conotoxin MII-Sensitive Nicotinic Acetylcholine Receptors in the Nucleus Accumbens Shell Regulate Progressive Ratio Responding Maintained by Nicotine

  2010cited by this paper
• Structural differences determine the relative selectivity of nicotinic compounds for native alpha 4 beta 2*-, alpha 6 beta 2*-, alpha 3 beta 4*- and alpha 7-nicotine acetylcholine receptors.

  2010cited by this paper
• Lynx1, a Cholinergic Brake, Limits Plasticity in Adult Visual Cortex

  2010cited by this paper
• Nicotinic Acetylcholine Receptors in the Mesolimbic Pathway: Primary Role of Ventral Tegmental Area α6β2* Receptors in Mediating Systemic Nicotine Effects on Dopamine Release, Locomotion, and Reinforcement

  2010cited by this paper
• Prominent Role of α3/α6β2* nAChRs in Regulating Evoked Dopamine Release in Primate Putamen: Effect of Long-Term Nicotine Treatment

  2009cited by this paper
• Treatments for Parkinson disease—past achievements and current clinical needs

  2009cited by this paper
• Mammalian nicotinic acetylcholine receptors: from structure to function.

  2009cited by this paper
• Fluoroquinolone resistance and mutation patterns in gyrA and parC genes in Neisseria gonorrhoeae isolates from Shanghai, China

  2009cited by this paper
• Nicotine-induced upregulation of nicotinic receptors: underlying mechanisms and relevance to nicotine addiction.

  2009cited by this paper
• Mysterious α6-containing nAChRs: function, pharmacology, and pathophysiology

  2009cited by this paper
• Desensitization of Nicotinic Acetylcholine Receptors as a Strategy for Drug Development

  2009cited by this paper
• When and how should treatment be started in Parkinson disease?

  2009cited by this paper
• Dopamine Signaling Differences in the Nucleus Accumbens and Dorsal Striatum Exploited by Nicotine

  2009cited by this paper
• Mechanistic studies of ethanol's interaction with the mesolimbic dopamine reward system.

  2009cited by this paper
• Nicotinic acetylcholine receptors and the ascending dopamine pathways.

  2009cited by this paper
• Diversity of vertebrate nicotinic acetylcholine receptors.

  2009cited by this paper
• Varenicline reduces alcohol self-administration in heavy-drinking smokers.

  2009cited by this paper
• The neuronal pathways mediating the behavioral and addictive properties of nicotine.

  2009cited by this paper
• Structural and functional diversity of native brain neuronal nicotinic receptors.

  2009cited by this paper
• Rodent Habenulo–Interpeduncular Pathway Expresses a Large Variety of Uncommon nAChR Subtypes, But Only the α3β4* and α3β3β4* Subtypes Mediate Acetylcholine Release

  2009cited by this paper
• Nicotinic acetylcholine receptor subunits in rhesus monkey retina.

  2009cited by this paper
• The Role of α6-Containing Nicotinic Acetylcholine Receptors in Nicotine Reward and Withdrawal

  2009cited by this paper
• The Role of (cid:1) 6-Containing Nicotinic Acetylcholine Receptors in Nicotine Reward and Withdrawal

  2009cited by this paper
• Levodopa in the treatment of Parkinson’s disease

  2009cited by this paper
• Nicotine is neuroprotective when administered before but not after nigrostriatal damage in rats and monkeys

  2009cited by this paper
• How do you treat motor complications in Parkinson's disease: Medicine, surgery, or both?

  2008cited by this paper
• Crucial Role of α4 and α6 Nicotinic Acetylcholine Receptor Subunits from Ventral Tegmental Area in Systemic Nicotine Self-Administration

  2008cited by this paper
• Subtypes of nicotinic acetylcholine receptors in nicotine reward, dependence, and withdrawal: evidence from genetically modified mice

  2008cited by this paper
• In vivo activation of midbrain dopamine neurons via sensitized, high-affinity alpha 6 nicotinic acetylcholine receptors.

  2008cited by this paper
• Transport of multiple nicotinic acetylcholine receptors in the rat optic nerve: high densities of receptors containing α6 and β3 subunits

  2008cited by this paper
• Up-regulation of Nicotinic Receptors by Nicotine Varies with Receptor Subtype*

  2008cited by this paper
• Involvement of the serotonin system in L-dopa-induced dyskinesias.

  2008cited by this paper
• Neuroprotection via nAChRs: the role of nAChRs in neurodegenerative disorders such as Alzheimer's and Parkinson's disease.

  2008cited by this paper
• ACh/dopamine crosstalk in motor control and reward: a crucial role for alpha 6-containing nicotinic receptors?

  2008cited by this paper
• Long-Term Nicotine Treatment Differentially Regulates Striatal α6α4β2* and α6(Nonα4)β2* nAChR Expression and Function

  2008cited by this paper
• Deep brain stimulation for Parkinson’s disease

  2008cited by this paper
• α6-Containing Nicotinic Acetylcholine Receptors Dominate the Nicotine Control of Dopamine Neurotransmission in Nucleus Accumbens

  2008cited by this paper
• Continuous and Intermittent Nicotine Treatment Reduces l-3,4-Dihydroxyphenylalanine (l-DOPA)-Induced Dyskinesias in a Rat Model of Parkinson's Disease

  2008cited by this paper
• It is not "either/or": activation and desensitization of nicotinic acetylcholine receptors both contribute to behaviors related to nicotine addiction and mood.

  2008cited by this paper
• Presynaptic nicotinic receptors: a dynamic and diverse cholinergic filter of striatal dopamine neurotransmission

  2008cited by this paper
• Neurobiology of nicotine addiction: implications for smoking cessation treatment.

  2008cited by this paper
• The neuronal nicotinic acetylcholine receptors α4* and α6* differentially modulate dopamine release in mouse striatal slices

  2008cited by this paper
• Alpha-conotoxin MII-sensitive nicotinic acetylcholine receptors are involved in mediating the ghrelin-induced locomotor stimulation and dopamine overflow in nucleus accumbens.

  2008cited by this paper
• Direct and indirect striatal efferent pathways are differentially influenced by low and high dyskinetic drugs: behavioural and biochemical evidence.

  2008cited by this paper
• Cell autonomy, receptor autonomy, and thermodynamics in nicotine receptor up-regulation.

  2007cited by this paper
• Nicotine neuroprotection against nigrostriatal damage: importance of the animal model.

  2007cited by this paper
• Nicotinic acetylcholine receptors in the ventral tegmental area mediate the dopamine activating and reinforcing properties of ethanol cues

  2007cited by this paper
• Chronic Nicotine Cell Specifically Upregulates Functional α4* Nicotinic Receptors: Basis for Both Tolerance in Midbrain and Enhanced Long-Term Potentiation in Perforant Path

  2007cited by this paper
• Rationale, pharmacology and clinical efficacy of partial agonists of alpha4beta2 nACh receptors for smoking cessation.

  2007cited by this paper
• Long-term effects of chronic nicotine exposure on brain nicotinic receptors

  2007cited by this paper
• Chronic nicotine differentially regulates alpha6- and beta3-containing nicotinic cholinergic receptors in rat brain.

  2007cited by this paper
• Chronic Nicotine Differentially Regulates α6- and β3-Containing Nicotinic Cholinergic Receptors in Rat Brain

  2007cited by this paper
• Nicotine reduces levodopa‐induced dyskinesias in lesioned monkeys

  2007cited by this paper
• Varenicline, an α4β2 nicotinic acetylcholine receptor partial agonist, selectively decreases ethanol consumption and seeking

  2007cited by this paper
• Nigrostriatal Damage Preferentially Decreases a Subpopulation of α6β2* nAChRs in Mouse, Monkey, and Parkinson's Disease Striatum

  2007cited by this paper
• Varenicline, an alpha4beta2 nicotinic acetylcholine receptor partial agonist, selectively decreases ethanol consumption and seeking.

  2007cited by this paper
• Rationale, pharmacology and clinical efficacy of partial agonists of α4β2 nACh receptors for smoking cessation

  2007cited by this paper
• Varenicline Is a Partial Agonist at α4β2 and a Full Agonist at α7 Neuronal Nicotinic Receptors

  2006cited by this paper
• Striatal alpha6* nicotinic acetylcholine receptors: potential targets for Parkinson's disease therapy.

  2006cited by this paper
• Increases in α4* but not α3*/α6* nicotinic receptor sites and function in the primate striatum following chronic oral nicotine treatment

  2006cited by this paper
• Varenicline is a partial agonist at alpha4beta2 and a full agonist at alpha7 neuronal nicotinic receptors.

  2006cited by this paper
• Selective down-regulation of [125I]Y0-α-conotoxin MII binding in rat mesostriatal dopamine pathway following continuous infusion of nicotine

  2006cited by this paper
• β3 Subunits Promote Expression and Nicotine-Induced Up-Regulation of Human Nicotinic α6* Nicotinic Acetylcholine Receptors Expressed in Transfected Cell Lines

  2006cited by this paper
• Selective nicotinic acetylcholine receptor subunit deficits identified in Alzheimer's disease, Parkinson's disease and dementia with Lewy bodies by immunoprecipitation.

  2006cited by this paper
• Differential Regulation of Mesolimbic α3*/α6β2* and α4β2* Nicotinic Acetylcholine Receptor Sites and Function after Long-Term Oral Nicotine to Monkeys

  2006cited by this paper
• Increases in alpha4* but not alpha3*/alpha6* nicotinic receptor sites and function in the primate striatum following chronic oral nicotine treatment.

  2006cited by this paper
• Striatal α6* Nicotinic Acetylcholine Receptors: Potential Targets for Parkinson's Disease Therapy

  2006cited by this paper
• Differential regulation of mesolimbic alpha 3/alpha 6 beta 2 and alpha 4 beta 2 nicotinic acetylcholine receptor sites and function after long-term oral nicotine to monkeys.

  2006cited by this paper
• Subunit Composition of Nicotinic Receptors in Monkey Striatum: Effect of Treatments with 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine or l-DOPA

  2005cited by this paper
• Nicotine reinforcement and cognition restored by targeted expression of nicotinic receptors

  2005cited by this paper
• Long-Term Nicotine Treatment Decreases Striatal α6* Nicotinic Acetylcholine Receptor Sites and Function in Mice

  2005cited by this paper
• Expression of nigrostriatal alpha 6-containing nicotinic acetylcholine receptors is selectively reduced, but not eliminated, by beta 3 subunit gene deletion.

  2005cited by this paper
• Nicotine upregulates its own receptors through enhanced intracellular maturation.

  2005cited by this paper
• Decrease in α3*/α6* Nicotinic Receptors but Not Nicotine-Evoked Dopamine Release in Monkey Brain after Nigrostriatal Damage

  2005cited by this paper
• Cholinergic nicotinic receptor involvement in movement disorders associated with Lewy body diseases : An autoradiography study using [125I]α-conotoxinMII in the striatum and thalamus

  2005cited by this paper
• Nicotine acts as a pharmacological chaperone to up-regulate human alpha4beta2 acetylcholine receptors.

  2005cited by this paper
• The mesolimbic dopaminergic system is implicated in the reinforcing effects of nicotine

  2005cited by this paper
• Heterogeneity and Selective Targeting of Neuronal Nicotinic Acetylcholine Receptor (nAChR) Subtypes Expressed on Retinal Afferents of the Superior Colliculus and Lateral Geniculate Nucleus: Identification of a New Native nAChR Subtype α3β2(α5 or β3) Enriched in Retinocollicular Afferents

  2005cited by this paper
• Decrease in alpha3*/alpha6* nicotinic receptors but not nicotine-evoked dopamine release in monkey brain after nigrostriatal damage.

  2005cited by this paper
• Expression of Nigrostriatal α6-Containing Nicotinic Acetylcholine Receptors Is Selectively Reduced, but Not Eliminated, by β3 Subunit Gene Deletion

  2005cited by this paper
• Nicotine Acts as a Pharmacological Chaperone to Up-Regulate Human α4β2 Acetylcholine Receptors

  2005cited by this paper
• Cholinergic nicotinic receptor involvement in movement disorders associated with Lewy body diseases. An autoradiography study using [(125)I]alpha-conotoxinMII in the striatum and thalamus.

  2005cited by this paper
• Nicotinic acetylcholine receptor subtypes expression during rat retina development and their regulation by visual experience.

  2004cited by this paper

• Nicotinic acetylcholine receptors-targeting drug discovery.

  2026cites this paper
• The Role of α7-Nicotinic Acetylcholine Receptors in the Pathophysiology and Treatment of Parkinson’s Disease

  2025cites this paper
• α-Conotoxin TxIB Reversed Nicotine-Induced Locomotor Sensitization and Nicotine-Enhanced Dopaminergic Activity in Mice

  2025cites this paper
• "Unraveling the role of CHRNA6, the neuronal α6 nicotinic acetylcholine receptor subunit".

  2025cites this paper
• α6 nicotinic acetylcholine receptors: A pharmacological challenge with untapped therapeutic promise.

  2025cites this paper
• Molecular insights into the α6β4 nicotinic acetylcholine receptor function and ligand recognition

  2025cites this paper
• Evaluation of the potential role of glutamatergic, cholinergic, and nitrergic systems in the dopamine release induced by the pesticide glyphosate in rat striatum

  2024cites this paper
• Catharanthine Modulates Mesolimbic Dopamine Transmission and Nicotine Psychomotor Effects via Inhibition of α6-Nicotinic Receptors and Dopamine Transporters.

  2024cites this paper
• Current Progress on Central Cholinergic Receptors as Therapeutic Targets for Alzheimer's Disease.

  2024cites this paper
• Possible Potentiating Effects of Combined Administration of Alcohol, Caffeine, and Nicotine on In Vivo Dopamine Release in Addiction-Related Circuits Within the CNS of Rats

  2024cites this paper
• Genomic factors associated with substance use disorder relapse: A critical review

  2024cites this paper
• The human alpha7 nicotinic acetylcholine receptor is a host target for the rabies virus glycoprotein

  2024cites this paper
• Discovery of CVN417, a Novel Brain-Penetrant α6-Containing Nicotinic Receptor Antagonist for the Modulation of Motor Dysfunction.

  2023cites this paper
• The role of nicotinic receptors in alcohol consumption.

  2023cites this paper
• Discovery, Characterization, and Engineering of LvIC, an α4/4-Conotoxin That Selectively Blocks Rat α6/α3β4 Nicotinic Acetylcholine Receptors.

  2023cites this paper
• Synthesis, Activity, and Application of Fluorescent Analogs of [D1G, Δ14Q]LvIC Targeting α6β4 Nicotinic Acetylcholine Receptor.

  2023cites this paper
• Loop2 Size Modification Reveals Significant Impacts on the Potency of α-Conotoxin TxID

  2023cites this paper
• PheSom: a term frequency-based method for measuring human phenotype similarity on the basis of MeSH vocabulary

  2023cites this paper
• Discovery and Structural and Functional Characterization of a Novel A-Superfamily Conotoxin Targeting α9α10 Nicotinic Acetylcholine Receptor.

  2022cites this paper
• Sex- and Genotype-Dependent Nicotine-Induced Behaviors in Adolescent Rats with a Human Polymorphism (rs2304297) in the 3′-UTR of the CHRNA6 Gene

  2022cites this paper
• Mechanisms Underlying Dopaminergic Regulation of Nicotine-Induced Kinetic Tremor

  2022cites this paper
• Interactions between the rabies virus and nicotinic acetylcholine receptors: A potential role in rabies virus induced behavior modifications

  2022cites this paper
• Multidimensional Intersection of Nicotine, Gene Expression, and Behavior

  2021cites this paper
• Worsening of chorea during smoking cessation therapy with cytisine: A case report

  2021cites this paper
• Simulations of Promising Indolizidine—α6-β2 Nicotinic Acetylcholine Receptor Complexes

  2021cites this paper
• α‐Conotoxin Bt1.8 from Conus betulinus selectively inhibits α6/α3β2β3 and α3β2 nicotinic acetylcholine receptor subtypes

  2021cites this paper
• Effects of Cyclization on Activity and Stability of α-Conotoxin TxIB

  2020cites this paper
• Conserved nicotine-activated neuroprotective pathways involve mitochondrial stress

  2020cites this paper
• Preclinical and Clinical Aspects of Nicotinic Acetylcholine Receptor Imaging

  2020cites this paper
• α-Conotoxin TxIB: A Uniquely Selective Ligand for α6/α3β2β3 Nicotinic Acetylcholine Receptor Attenuates Nicotine-Induced Conditioned Place Preference in Mice

  2019cites this paper
• Marine-Derived Natural Compounds for the Treatment of Parkinson’s Disease

  2019cites this paper
• α6-Containing Nicotinic Acetylcholine Receptor Reconstitution Involves Mechanistically Distinct Accessory Components.

  2019cites this paper
• Characterization of AN6001, a positive allosteric modulator of α6β2-containing nicotinic acetylcholine receptors.

  2019cites this paper
• Characterization of AN317, a novel selective agonist of α6β2-containing nicotinic acetylcholine receptors.

  2019cites this paper
• Specificity of a rodent alpha(α)6 nicotinic acetylcholine receptor subunit antibody

  2019cites this paper
• α-Conotoxin VnIB from Conus ventricosus is a potent and selective antagonist of α6β4* nicotinic acetylcholine receptors.

  2019cites this paper
• Expression in Escherichia coli of fusion protein comprising α‐conotoxin TxIB and preservation of selectivity to nicotinic acetylcholine receptors in the purified product

  2018cites this paper
• The striatal cholinergic system in l-dopa-induced dyskinesias

  2018cites this paper
• 18F-XTRA PET for Enhanced Imaging of the Extrathalamic α4β2 Nicotinic Acetylcholine Receptor

  2018cites this paper
• Alpha6-Containing Nicotinic Acetylcholine Receptors Mediate Nicotine-Induced Structural Plasticity in Mouse and Human iPSC-Derived Dopaminergic Neurons

  2018cites this paper
• The contribution of agonist and antagonist activities of α4β2* nAChR ligands to smoking cessation efficacy: a quantitative analysis of literature data

  2018cites this paper
• A characterization of laminar architecture in mouse primary auditory cortex

  2018cites this paper
• Dopaminergic Neurons in the Ventral Tegmental Area and Their Dysregulation in Nicotine Addiction

  2018cites this paper
• Deletion of lynx1 reduces the function of α6* nicotinic receptors

  2017cites this paper
• RIC-3, a potential target for regulating cholinergic signaling and inflammation

  2017cites this paper
• Interactions of Alcohol and Nicotine

  2017cites this paper
• α6β2 nicotinic acetylcholine receptors influence locomotor activity and ethanol consumption.

  2017cites this paper
• High-Throughput Patch Clamp Screening in Human α6-Containing Nicotinic Acetylcholine Receptors

  2017cites this paper
• α7 Nicotinic acetylcholine receptor-mediated anti-inflammatory actions modulate brain functions

  2016cites this paper
• The impact of antipsychotics on the trafficking of neurotransmitter receptors

  2016cites this paper
• Neuronal Nicotinic Acetylcholine Receptor Modulators Reduce Sugar Intake

  2016cites this paper
• Diversity of native nicotinic receptor subtypes in mammalian brain.

  2015cites this paper
• Beneficial effects of nicotine, cotinine and its metabolites as potential agents for Parkinson’s disease

  2015cites this paper
• Cholinergic interneurons in the dorsal and ventral striatum: anatomical and functional considerations in normal and diseased conditions

  2015cites this paper
• Expression of cloned α6* nicotinic acetylcholine receptors.

  2015cites this paper
• Conotoxins and Drug Discovery With Special Reference to Hainan Species

  2015cites this paper
• Chronic Nicotine Exposure Attenuates Methamphetamine-Induced Dopaminergic Deficits

  2015cites this paper
• Effects of TI-299423 on Neuronal Nicotinic Acetylcholine Receptors

  2015cites this paper
• COPI polices nicotine-mediated up-regulation of nicotinic receptors

  2014cites this paper
• A novel α4/7‐conotoxin LvIA from Conus lividus that selectively blocks α3β2 vs. α6/α3β2β3 nicotinic acetylcholine receptors

  2014cites this paper
• The potent and selective α4β2*/α6*-nicotinic acetylcholine receptor partial agonist 2-[5-[5-((S)Azetidin-2-ylmethoxy)-3-pyridinyl]-3-isoxazolyl]ethanol demonstrates antidepressive-like behavior in animal models and a favorable ADME-tox profile

  2014cites this paper
• Recent Developments in Novel Antidepressants Targeting α4β2-Nicotinic Acetylcholine Receptors

  2014cites this paper
• Presynaptic Nicotinic Acetylcholine Receptors: Subtypes and Functions

  2014cites this paper
• Diverse strategies targeting alpha 7 homomeric and alpha 6 beta 2 * heteromeric nicotinic acetylcholine receptors for smoking cessation

  2014cites this paper
• Acute Ethanol Inhibits Dopamine Release in the Nucleus Accumbens via α6 Nicotinic Acetylcholine Receptors

  2014cites this paper
• α6β2*‐subtype nicotinic acetylcholine receptors are more sensitive than α4β2*‐subtype receptors to regulation by chronic nicotine administration

  2014cites this paper
• ubsynaptic localization of nicotinic acetylcholine receptor subunits : comparative study in the mouse and rat striatum

  2014cites this paper
• Preclinical Aspects of Nicotinic Acetylcholine Receptor Imaging

  2014cites this paper
• Biophysical and pharmacological characterization of α6-containing nicotinic acetylcholine receptors expressed in HEK293 cells.

  2014cites this paper
• Mice expressing the ADNFLE valine 287 leucine mutation of the Β2 nicotinic acetylcholine receptor subunit display increased sensitivity to acute nicotine administration and altered presynaptic nicotinic receptor function.

  2013cites this paper
• α4β2 Nicotinic receptors play a role in the nAChR-mediated decline in L-dopa-induced dyskinesias in parkinsonian rats.

  2013cites this paper
• Optimal Cleavage and Oxidative Folding of α-Conotoxin TxIB as a Therapeutic Candidate Peptide

  2013cites this paper
• Functional interaction between pre‐synaptic α6β2‐containing nicotinic and adenosine A2A receptors in the control of dopamine release in the rat striatum

  2013influential citation
• Elucidation of Molecular Impediments in the α6 Subunit for in Vitro Expression of Functional α6β4* Nicotinic Acetylcholine Receptors*

  2013cites this paper
• Chemistry, pharmacology, and behavioral studies identify chiral cyclopropanes as selective α4β2-nicotinic acetylcholine receptor partial agonists exhibiting an antidepressant profile. Part II.

  2013cites this paper
• Nicotine-mediated improvement in L-dopa-induced dyskinesias in MPTP-lesioned monkeys is dependent on dopamine nerve terminal function.

  2013cites this paper
• Varenicline and nicotine enhance GABAergic synaptic transmission in rat CA1 hippocampal and medial septum/diagonal band neurons.

  2013cites this paper
• The 3,7-diazabicyclo[3.3.1]nonane scaffold for subtype selective nicotinic acetylcholine receptor (nAChR) ligands. Part 1: the influence of different hydrogen bond acceptor systems on alkyl and (hetero)aryl substituents.

  2013cites this paper
• Nicotine Reduces Antipsychotic-Induced Orofacial Dyskinesia in Rats

  2012influential citation
• Structure-activity studies of 7-heteroaryl-3-azabicyclo[3.3.1]non-6-enes: a novel class of highly potent nicotinic receptor ligands.

  2012cites this paper
• Role for α6 nicotinic receptors in l-dopa-induced dyskinesias in parkinsonian mice.

  2012cites this paper
• Characterization of a Novel α-Conotoxin from Conus textile That Selectively Targets α6/α3β2β3 Nicotinic Acetylcholine Receptors*

  2012cites this paper
• Low concentrations of nicotine differentially desensitize nicotinic acetylcholine receptors that include α5 or α6 subunits and that mediate synaptosomal neurotransmitter release.

  2012cites this paper
• Novel α-CTx TxIB Selectively Blocks α 6 / α 3 β 2 β 3 nAChRs 1 Characterization of a Novel α-Conotoxin from Conus textile that Selectively Targets α 6 / α 3 β 2 β 3 Nicotinic Acetylcholine Receptors

  2012cites this paper
• Diurnal Evening Type is Associated with Current Smoking, Nicotine Dependence and Nicotine Intake in the Population Based National FINRISK 2007 Study.

  2012cites this paper
• In vitro exposure to nicotine induces endocytosis of presynaptic AMPA receptors modulating dopamine release in rat nucleus accumbens nerve terminals.

  2012cites this paper
• Progress and challenges in the study of α6-containing nicotinic acetylcholine receptors.

  2011cites this paper
• Annals of the New York Academy of Sciences Diverse Strategies Targeting ␣7 Homomeric and ␣6␤2 * Heteromeric Nicotinic Acetylcholine Receptors for Smoking Cessation

  year unknowncites this paper